The National Human Genome Research Institute awarded a purchase order to Greenwood Genetic Center Inc. for specialized genetic testing services on September 26, 2026, with a ceiling value of $49,350.00 and final performance due September 25, 2027. Work is performed in Greenwood, South Carolina. The purchase order supports the NHGRI Undiagnosed Diseases Program, providing laboratory testing for diagnostic evaluations and research activities for patients with complex, chronic, and previously undiagnosed medical conditions enrolled under clinical protocol 15-HG-0130. Testing services address rare genetic, epigenetic, metabolic, and lysosomal disorders to identify disease etiologies and establish diagnoses. This acquisition continues genetic testing services previously provided under NIH purchase order 75N92025P00400.